A | B | C | D | E | F | G | H | I | J | K | L | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ||||||||||||
2 | Name | Indication | Phase | MOA | Economics | Admin | IP | Price | 43.91 | |||
3 | Zulresso (brexanolone) | PPD | GABA | Shares | 59.717608 | Q422 | ||||||
4 | zuranolone | MDD, PPD | 8/5/2023 PDUFA | GABAA pam | BIIB | Oral | MC | 2622.2001672799997 | ||||
5 | SAGE-324 | ET | GABA pam | BIIB | Oral | Cash | 1272.4940000000001 | Q422 | ||||
6 | SAGE-718 | Huntington's | NMDA pam | Debt | 0 | Q422 | ||||||
7 | EV | 1349.7061672799996 | ||||||||||
8 | ||||||||||||
9 | Employees | 689 | Q422 | |||||||||
10 | ||||||||||||
11 | AD | -2028.17 | Q422 | |||||||||
12 | ||||||||||||
13 | ||||||||||||
14 | Founded | 2010 |